Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AUT00206
AUT00206
Boehringer calls off €627M deal with GSK spinout, passing on schizophrenia drug option
Endpoints
Wed, 08/26/20 - 11:09 am
Boehringer Ingelheim
GSK
schizophrenia
Autifony
AUT00206